Related Experiment Video

Updated: Jul 8, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Special issues in pediatric inflammatory bowel disease

Marla Dubinsky1

  • 1Pediatric IBD Center, Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California-Los Angeles, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. dubinskym@csmc.edu

World Journal of Gastroenterology
|January 18, 2008
PubMed

Insights

Pediatric inflammatory bowel disease (IBD) management requires tailored approaches, considering developmental stages and the crucial transition to adult care. Early diagnosis and specialized interventions are key for improving outcomes in children with IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Child Development

Background:

  • Rising incidence of pediatric inflammatory bowel disease (IBD).
  • Advances in diagnostics and therapeutics for pediatric IBD.
  • Unique characteristics of early-onset versus adult-onset IBD.

Purpose of the Study:

  • To highlight special considerations in managing pediatric inflammatory bowel disease (IBD).
  • To emphasize the importance of developmental stages in pediatric IBD care.
  • To address the critical transition from pediatric to adult IBD care.

Main Methods:

  • Review of current literature on pediatric inflammatory bowel disease.
  • Analysis of distinguishing features between early-onset and adult-onset IBD.
  • Discussion of physical and psychosocial development in pediatric IBD management.

Main Results:

  • Pediatric IBD presents distinct features compared to adult-onset disease.
  • Physical and psychosocial development significantly impacts disease presentation and management.
  • Successful transition to adult care requires specific considerations.

Conclusions:

  • Comprehensive management of pediatric IBD must account for developmental stages.
  • Specialized care is essential for children with inflammatory bowel disease.
  • Transition planning is a critical component of long-term pediatric IBD care.

More Related Videos

Tissue Engineering of the Intestine in a Murine Model08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...